Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility study

Abstract

This study reports UK population utilities for a universal set of CLL health states that incorporate intended treatment response and unintended toxicities. These utilities can be applied in future cost-effectiveness analyses of CLL treatment.